HHS Drafts Enforcement Discretion for Peptide-Based 503A Compounding

HHS on October 30, 2026 published in the Federal Register a draft interim enforcement discretion policy on 503A compounding using certain peptide bulk drug substances, putting a new pathway on notice for comment.